Karuna Therapeutics, Inc. Shareholders' Equity
Karuna Therapeutics, Inc. had Shareholders' Equity of $1.25 billion as of 2023-12-31, per its 10-K filed 2024-02-22.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2024-02-22
- 2023-12-31: Stockholders' Equity Attributable to Parent $1.25B.
- 2023-09-30: Stockholders' Equity Attributable to Parent $1.32B.
- 2023-06-30: Stockholders' Equity Attributable to Parent $1.42B.
- 2023-03-31: Stockholders' Equity Attributable to Parent $1.49B.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2023-12-31 | $1.25B 10-K · filed 2024-02-22 |
| 2023-09-30 | $1.32B 10-Q · filed 2023-11-02 |
| 2023-06-30 | $1.42B 10-Q · filed 2023-11-02 |
| 2023-03-31 | $1.49B 10-Q · filed 2023-08-03 |
| 2022-12-31 | $1.13B 10-K · filed 2024-02-22 |
| 2022-09-30 | $1.18B 10-Q · filed 2023-11-02 |
| 2022-06-30 | $405.41M 10-Q · filed 2023-11-02 |
| 2022-03-31 | $453.69M 10-Q · filed 2023-08-03 |
| 2021-12-31 | $502.03M 10-K · filed 2024-02-22 |
| 2021-09-30 | $518.33M 10-Q · filed 2022-11-03 |
| 2021-06-30 | $560.34M 10-Q · filed 2022-11-03 |
| 2021-03-31 | $584.91M 10-Q · filed 2022-08-08 |
| 2020-12-31 | $338.93M 10-K · filed 2024-02-22 |
| 2020-09-30 | $357.26M 10-Q · filed 2021-11-04 |
| 2020-06-30 | $371.80M 10-Q · filed 2021-11-04 |
| 2020-03-31 | $384.94M 10-Q · filed 2021-08-05 |
| 2019-12-31 | $389.92M 10-K · filed 2023-02-23 |
| 2019-09-30 | $162.53M 10-Q · filed 2020-11-05 |
| 2019-06-30 | -$46.99M 10-Q · filed 2020-11-05 |
| 2019-03-31 | -$38.77M 10-Q · filed 2020-08-05 |
| 2018-12-31 | -$29.92M 10-K · filed 2022-02-24 |
| 2018-09-30 | -$22.01M 10-Q · filed 2019-11-07 |
| 2018-06-30 | -$16.19M 10-Q · filed 2019-11-07 |
| 2018-03-31 | -$15.72M 10-Q · filed 2019-08-08 |
| 2017-12-31 | -$13.37M 10-K · filed 2021-02-25 |